questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Indolizine
Indolizidines
Alcaloïdes indoliques
Alcaloïdes formés par condensation de sécologanine et de tryptamine
Alcaloïdes de Vinca
Vincristine
Vincristine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Vincristine
Cancer
Diagnostic
Tests de laboratoire
Imagerie médicale
Vincristine
Symptômes
2
Effets secondaires
Neuropathie
Vincristine
Douleur
Neuropathie
Vincristine
Prévention
2
Prévention
Effets secondaires
Vincristine
Évaluation médicale
Vincristine
Préparation au traitement
Traitements
2
Chimiothérapie
Vincristine
Prednisone
Administration intraveineuse
Vincristine
Chimiothérapie
Complications
2
Complications
Infections
Vincristine
Problèmes cardiaques
Vincristine
Surveillance médicale
Facteurs de risque
2
Facteurs de risque
Neuropathie
Vincristine
Antécédents médicaux
Vincristine
Neurologie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vincristine : Questions médicales les plus fréquentes",
"headline": "Vincristine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vincristine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-27",
"dateModified": "2025-02-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vincristine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Alcaloïdes de Vinca",
"url": "https://questionsmedicales.fr/mesh/D014748",
"about": {
"@type": "MedicalCondition",
"name": "Alcaloïdes de Vinca",
"code": {
"@type": "MedicalCode",
"code": "D014748",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.496.500.500.681.827"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vincristine",
"alternateName": "Vincristine",
"code": {
"@type": "MedicalCode",
"code": "D014750",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Wenjian Yang",
"url": "https://questionsmedicales.fr/author/Wenjian%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Deqing Pei",
"url": "https://questionsmedicales.fr/author/Deqing%20Pei",
"affiliation": {
"@type": "Organization",
"name": "Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Cheng Cheng",
"url": "https://questionsmedicales.fr/author/Cheng%20Cheng",
"affiliation": {
"@type": "Organization",
"name": "Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "William E Evans",
"url": "https://questionsmedicales.fr/author/William%20E%20Evans",
"affiliation": {
"@type": "Organization",
"name": "Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Richard H Ho",
"url": "https://questionsmedicales.fr/author/Richard%20H%20Ho",
"affiliation": {
"@type": "Organization",
"name": "Vanderbilt University Medical Center, Nashville, TN."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Half-life determination of",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36209648",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.apradiso.2022.110480"
}
},
{
"@type": "ScholarlyArticle",
"name": "Half-life measurement of",
"datePublished": "2022-10-06",
"url": "https://questionsmedicales.fr/article/36228535",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.apradiso.2022.110507"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Practical Importance of Half-Life in Psychopharmacology.",
"datePublished": "2022-07-25",
"url": "https://questionsmedicales.fr/article/35900254",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4088/JCP.22f14584"
}
},
{
"@type": "ScholarlyArticle",
"name": "The influence of thyroid hormone medication on intra-therapeutic half-life of",
"datePublished": "2022-08-17",
"url": "https://questionsmedicales.fr/article/35978004",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-18170-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical outcomes of low-dose pharmacokinetic-guided extended half-life versus low-dose standard half-life factor VIII concentrate prophylaxis in haemophilia A patients.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36409282",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/hae.14700"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Indolizine",
"item": "https://questionsmedicales.fr/mesh/D007212"
},
{
"@type": "ListItem",
"position": 6,
"name": "Indolizidines",
"item": "https://questionsmedicales.fr/mesh/D054836"
},
{
"@type": "ListItem",
"position": 7,
"name": "Alcaloïdes indoliques",
"item": "https://questionsmedicales.fr/mesh/D026121"
},
{
"@type": "ListItem",
"position": 8,
"name": "Alcaloïdes formés par condensation de sécologanine et de tryptamine",
"item": "https://questionsmedicales.fr/mesh/D046948"
},
{
"@type": "ListItem",
"position": 9,
"name": "Alcaloïdes de Vinca",
"item": "https://questionsmedicales.fr/mesh/D014748"
},
{
"@type": "ListItem",
"position": 10,
"name": "Vincristine",
"item": "https://questionsmedicales.fr/mesh/D014750"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vincristine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vincristine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vincristine",
"description": "Comment la vincristine est-elle utilisée dans le diagnostic ?\nQuels tests précèdent l'administration de vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Half-Life#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vincristine",
"description": "Quels sont les effets secondaires de la vincristine ?\nLa vincristine cause-t-elle des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Half-Life#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vincristine",
"description": "Peut-on prévenir les effets secondaires de la vincristine ?\nY a-t-il des recommandations avant le traitement par vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Half-Life#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vincristine",
"description": "Avec quels médicaments la vincristine est-elle souvent combinée ?\nComment la vincristine est-elle administrée ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Half-Life#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vincristine",
"description": "Quelles complications peuvent survenir avec la vincristine ?\nLa vincristine peut-elle causer des problèmes cardiaques ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Half-Life#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vincristine",
"description": "Qui est à risque d'effets indésirables de la vincristine ?\nLes antécédents médicaux influencent-ils le traitement par vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Half-Life#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la vincristine est-elle utilisée dans le diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vincristine n'est pas un outil de diagnostic, mais un traitement pour des cancers diagnostiqués."
}
},
{
"@type": "Question",
"name": "Quels tests précèdent l'administration de vincristine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des examens d'imagerie sont effectués pour évaluer la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la vincristine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent neuropathie, constipation, et fatigue."
}
},
{
"@type": "Question",
"name": "La vincristine cause-t-elle des douleurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs neuropathiques chez certains patients."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les effets secondaires de la vincristine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures préventives incluent une surveillance étroite et des médicaments pour les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations avant le traitement par vincristine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une évaluation médicale complète est recommandée avant le traitement."
}
},
{
"@type": "Question",
"name": "Avec quels médicaments la vincristine est-elle souvent combinée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est souvent combinée avec la prednisone et d'autres agents chimiothérapeutiques."
}
},
{
"@type": "Question",
"name": "Comment la vincristine est-elle administrée ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vincristine est administrée par voie intraveineuse, généralement en cycle."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la vincristine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections, des troubles neurologiques et des problèmes gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "La vincristine peut-elle causer des problèmes cardiaques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que rare, des problèmes cardiaques peuvent survenir, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'effets indésirables de la vincristine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients âgés et ceux avec des antécédents de neuropathie sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le traitement par vincristine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies neurologiques peuvent affecter le traitement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Vanderbilt University Medical Center, Nashville, TN.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.
High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.
High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Mental Health Institute of the Second Xiangya Hospital, Central South University, Chinese National Clinical Research Center on Mental Disorders (xiangya), Chinese National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health, Changsha, Hunan 410011, China.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States.
Center for Lung Regenerative Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Division of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Vincristine" :
Terbium-155 has been identified for its potential for single-photon emission computed tomography (SPECT) in nuclear medicine. For activity measurements, an accurate and precise half-life of this radio...
The half-life of a drug is most commonly defined as the time taken for the plasma or blood level of the drug to fall by half. Elimination half-life, pharmacologic half-life, and biologic half-life are...
Despite a significantly improved dietary iodine supply, solitary toxic thyroid nodules (STN) are still a common clinical problem in former iodine deficient areas. Radioiodine treatment (RIT) is a well...
Despite receiving standard half-life (SHL) factor VIII (FVIII) concentrates prophylaxis, some severe haemophilia A (HA) patients still encounter spontaneous breakthrough bleeding. Individualized pharm...
To compare clinical outcomes before and after switching low-dose prophylaxis using weight-based SHL FVIII to PK-guided EHL FVIII concentrates, taking into consideration of a trough FVIII activity at 1...
In this single-centre prospective cohort, Thai severe or moderate HA (FVIII activity ≤3 IU/dl) patients receiving low-dose weight-based SHL FVIII prophylaxis were enrolled. After a 3-day wash-out peri...
Of 15 eligible subjects (mean age 18.7 ± 6.7 years), ABR, AJBR and HJHS were significantly reduced (mean differences of -11.1 ± 4.9 bleeds/year, -10.4 ± 5.2 joint bleeds/year and -5.1 ± 1.5 marks, res...
This is the first low-dose, PK-guided, EHL FVIII prophylaxis clinical study in Thailand. Benefits and practicability of this personalized regimen may support the implementation of regular FVIII prophy...
gov NCT05281185....
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is primarily transmitted from person to person through respiratory droplets and aerosols. It is also possible for the virus to be transmitt...
Proteolysis is an essential process to maintain cellular homeostasis. One pathway that mediates selective protein degradation and which is in principle conserved throughout the kingdoms of life is the...
Pesticide dissipation half-life in plants is an important factor to assessing environmental fate of pesticides and establishing pre-harvest intervals critical to good agriculture practices. However, e...
Sixty years after the discovery of...
Radioiodine therapy has been widely used for ablation of remnant tissue after surgical treatment of differentiated thyroid carcinoma (DTC). Internal dosimetry provides a new approach to choosing the a...